We are live on ! Find out more
CA

Cortland Associates Portfolio holdings

AUM $692M Turnover 14.93%
1-Year Est. Return 5%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
-5%
3 Year Est. Return
+57.07%
5 Year Est. Return
+61.48%
10 Year Est. Return
+413.35%
AUM
$420M
AUM Growth
-$81.2M
Cap. Flow
-$77M
Cap. Flow %
-18.36%
Top 10 Hldgs %
80.43%
Holding
42
New
3
Increased
6
Reduced
13
Closed
1
Avg Time Held
1 year
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1.1 years

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$9.13M
2
CTSH icon
Cognizant
CTSH
+$7.34M
3
CLB icon
Core Laboratories
CLB
+$6.2M
4
AAPL icon
Apple
AAPL
+$243K
5
EMR icon
Emerson Electric
EMR
+$208K

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$60.1M
2
COF icon
Capital One
COF
+$24.8M
3
IDXX icon
Idexx Laboratories
IDXX
+$13.2M
4
V icon
Visa
V
+$369K
5
ICE icon
Intercontinental Exchange
ICE
+$321K

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 19.38%
3 Technology 16.74%
4 Communication Services 12.31%
5 Materials 10.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CTSH icon
1
Cognizant
CTSH
$29.7B
$53.8M 12.82%
1,201,130
+155,985
+15% +$7.34M
2013 Q2
5 quarters
V icon
2
Visa
V
$756B
$49.4M 11.77%
925,300
-6,860
-0.7% -$369K
2013 Q2
5 quarters
ESRX
3
DELISTED
Express Scripts Holding Company
ESRX
$38.5M 9.19%
545,644
-843,540
-61% -$60.1M
2013 Q2
5 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.12T
$37.4M 8.91%
1,281,449
-8,443
-0.7% -$244K
2013 Q2
5 quarters
DHR icon
5
Danaher
DHR
$161B
$35.2M 8.4%
690,189
-3,772
-0.5% -$194K
2013 Q2
5 quarters
CVS icon
6
CVS Health
CVS
$118B
$28.4M 6.76%
356,567
+115,767
+48% +$9.13M
2013 Q2
5 quarters
PX icon
7
DELISTED
Praxair Inc
PX
$26.2M 6.25%
203,145
-649
-0.3% -$85.1K
2013 Q2
5 quarters
EBAY icon
8
eBay
EBAY
$53.5B
$25.8M 6.14%
1,080,365
-11,991
-1% -$267K
2013 Q2
5 quarters
ICE icon
9
Intercontinental Exchange
ICE
$90.7B
$23.5M 5.6%
602,285
-8,370
-1% -$321K
2013 Q2
5 quarters
FAST icon
10
Fastenal
FAST
$58.5B
$19.3M 4.6%
1,720,056
-4,528
-0.3% -$51.8K
2013 Q2
5 quarters
MON
11
DELISTED
Monsanto Co
MON
$17.9M 4.28%
159,506
-921
-0.6% -$108K
2013 Q2
5 quarters
QCOM icon
12
Qualcomm
QCOM
$184B
$15M 3.59%
201,241
-2,828
-1% -$216K
2013 Q2
5 quarters
BIDU icon
13
Baidu
BIDU
$27.3B
$14.2M 3.39%
65,159
-939
-1% -$199K
2013 Q2
5 quarters
IDXX icon
14
Idexx Laboratories
IDXX
$44.1B
$11.4M 2.73%
194,314
-209,514
-52% -$13.2M
2013 Q2
5 quarters
AON icon
15
Aon
AON
$62.1B
$8.03M 1.91%
91,540
-22
-0% -$1.92K
2013 Q3
4 quarters
CLB icon
16
Core Laboratories
CLB
$459M
$5.88M 1.4%
+40,162
New +$6.2M
2014 Q3
0 quarters
IBM icon
17
IBM
IBM
$219B
$787K 0.19%
4,337
– –
2013 Q2
5 quarters
PM icon
18
Philip Morris
PM
$320B
$571K 0.14%
6,845
– –
2013 Q2
5 quarters
PBA icon
19
Pembina Pipeline
PBA
$29.1B
$503K 0.12%
11,939
– –
2013 Q2
5 quarters
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.14T
$419K 0.1%
3,035
– –
2013 Q2
5 quarters
ECYT
21
DELISTED
Endocyte, Inc. Common Stock
ECYT
$401K 0.1%
66,000
+3,000
+5% +$20.5K
2013 Q4
3 quarters
JNJ icon
22
Johnson & Johnson
JNJ
$616B
$386K 0.09%
3,624
+200
+6% +$20.7K
2013 Q2
5 quarters
IWB icon
23
iShares Russell 1000 ETF
IWB
$48.7B
$360K 0.09%
3,275
– –
2013 Q2
5 quarters
IYY icon
24
iShares Dow Jones US ETF
IYY
$2.99B
$359K 0.09%
7,250
– –
2013 Q2
5 quarters
XOM icon
25
ExxonMobil
XOM
$736B
$286K 0.07%
3,036
+500
+20% +$49.8K
2013 Q2
5 quarters
1
2

Similar funds

BFC
Blue Fin Capital Warren, Rhode Island $692M AUM 27.29% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $692M AUM 32% 1-Year Est. Return
SIA
SeaBridge Investment Advisors Summit, New Jersey $692M AUM 52.26% 1-Year Est. Return
BSG
Black Swift Group Boulder, Colorado $692M AUM 44.95% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $692M AUM 15.25% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
CT
Chicago Trust Grayslake, Illinois $690M AUM 33.05% 1-Year Est. Return
TCMI
Technology Crossover Management IX Menlo Park, California $690M AUM 42.34% 1-Year Est. Return

Cortland Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Cortland Associates held 42 positions worth $420M, down 16% from $501M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Cortland Associates withdrew a net $77M in Q3 2014, closing 1 position and reducing 13 holdings. Its most notable exit was Capital One, an estimated $24.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 36% a quarter earlier, followed by Financials and Technology.

Against the trend, Cortland Associates opened a new position in Core Laboratories worth $5.88M.

  • Cortland Associates's largest Q3 2014 buy was Core Laboratories: 40,162 shares worth $5.88M.
  • Cortland Associates added most to CVS Health in Q3 2014, an estimated $9.13M increase.
  • Cortland Associates's biggest Q3 2014 reduction was Express Scripts Holding Company, cutting an estimated $60.1M.
  • Cortland Associates fully exited Capital One in Q3 2014, selling an estimated $24.8M.
  • Cortland Associates's ten largest holdings make up 80% of its $420M portfolio in Q3 2014.
  • Cortland Associates opened 3 new positions and closed 1 in Q3 2014.
  • Cortland Associates's portfolio value fell 16% quarter-over-quarter to $420M.

Based on Cortland Associates's 13F filing for Q3 2014, filed 22 Oct 2014.